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G-protein-coupled receptors (GPCRs) are dynamically regulated by various 
mechanisms, which tune their response to external stimuli. Modulation of their 
plasma membrane density, via trafficking between sub-cellular compartments, 
constitutes an important process in this context. Substantial information has 
been accumulated on cellular pathways, which remove GPCRs from the cell 
surface for subsequent degradation or recycling.  In comparison, much less is 
known about mechanisms controlling trafficking of neo-synthesised GPCRs 
from intracellular compartments to the cell surface. Although GPCR export to 
the plasma membrane is commonly considered to mostly implicate the default, 
unregulated secretory pathway, an increasing number of observations indicate 
that trafficking to the plasma membrane from the endoplasmic reticulum may 
be tightly regulated and involve specific protein partners. Moreover, a new 
paradigm is emerging in some cellular contexts, in which stocks of functional 
receptors retained within intracellular compartments may be rapidly mobilized 
to the plasma membrane to maintain sustained physiological responsiveness.  
  
Established models of GPCR maturation  
Introduction 
Polytopic proteins (spanning membranes several times) are synthesized by 
ribosomes attached at the cytosolic face of the endoplasmic reticulum (ER) and enter 
cotranslationally in the ER lumen via a translocation complex (the translocon), to which they 
are targeted by hydrophobic signal sequences (Figure 1). Membrane insertion of 
transmembrane domains is driven by the translocon and orientation signals contained in the 
polypeptidic chain itself and it is assisted by molecular chaperones and folding factors1, 2. 
Most polytopic proteins fold properly with the aid of the general chaperone system, which 
comprises classical and lectin chaperones, in addition to enzymes that catalyze disulfide 
bond formation or peptidyl-prolyl cis-trans isomerization3,4. Once polytopic proteins have 
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achieved their native conformation, they leave the ER and are transported through the 
secretory pathway to their destination. This complex ER machinery constitutes the major 
quality-control system for proof-reading newly synthesized proteins: folding-defective 
polypeptides are exported across the ER membrane into the cytosol and destroyed by the 
ER-associated degradation pathway (ERAD)5.  
Several studies have investigated the implication of the general chaperone system in 
GPCR folding. The Hsp70 family ER luminal protein BiP/GRP78 is the master regulator of 
the ER. Assisted by Hsp40 family co-factors, BiP facilitates translocation of nascent chains in 
the ER lumen, participates in protein folding and oligomerization and contributes to the retro-
translocation of misfolded proteins to ERAD4. Some GPCRs, such as thyrotropin-releasing 
hormone receptor (TRH receptor) and lutenizing hormone receptor (LSH receptor), were 
reported to interact with BiP6,7. LSH receptor, was also found to interact in the ER with 
GRP94, a member of the Hsp90 family and Bip cofactor7. GRP94 likely interacts with more 
advanced folding intermediates than BiP, since it binds some substrates that have been 
released from BiP4. N-glycosylation of the aminoterminal region or of extracellular loops 
(which are luminal in the ER) is common among GPCRs. Cotranslational addition of a 
Glucose3Mannose9N-acetylglucosamine2 chain to asparagine residues by the 
oligosaccharyltransferase provides binding sites for carbohydrate-binding lectin chaperones 
such as calnexin and calreticulin. After the removal of the 2 terminal glucoses by a 
glucosidase, monoglucosylated nascent proteins interact with lectin chaperones, the 
interaction being terminated by the cleavage of the last glucose by glucosidase II. Once 
released, correctly folded glycoproteins can exit the ER. In contrast, incorrectly or 
incompletely folded glycoproteins are re-glucosylated by glucosyltransferase promoting a 
renewed association with calnexin and calreticulin. Cycles of glucosylation and de-
glucosylation continue until the glycoprotein has either reached its native conformation or is 
targeted for degradation3. As expected from the GPCR glycosylation profile, multiple reports 
illustrate the interaction between GPCRs and carbohydrate-binding chaperones6-12. 
Interestingly, ER-retained receptor mutants were found to display enhanced interaction with 
both carbohydrate-binding chaperones and/or BiP9,13. Finally, several reports documented 
the degradation of wild type or mutant GPCRs by ERAD12,14,15. The developing field of the 
proteomic analysis of GPCR-associated protein complexes16 will likely confirm that 
interaction with the general chaperone system is a common feature for all receptors. 
 
Post ER trafficking 
Exit of proteins from the ER occurs at ER exit sites, where buds are formed and 
coated with the COPII coat under the control of the Sar1p GTPase. Proteins released from 
the ER quality control machinery accumulate in these buds17. A recent study provided 
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experimental evidence that ER exit of GPCRs is indeed mediated through Sar1-dependent 
COPII-coated vesicles18. Signals in the cytoplasmically exposed C-terminal tails of 
transmembrane protein cargos (i.e. the transmembrane proteins that are being transported in 
the secretory pathway) are likely involved in direct binding with components of COPII19.  
These signals comprise di-acidic motifs (DXE or similar) and pairs of aromatic (FF, YY or FY) 
or bulky hydrophobic (LL or IL) amino acid residues17. Cargo receptors for soluble secretory 
proteins present in ER buds also possess these motifs in their carboxyterminal tail. Many 
GPCRs contain similar ER export motifs 20, suggesting that they might interact directly with 
COPII complex proteins, although experimental evidence for this is lacking.  
In mammalian cells, protein traffic moving from ER-exit sites to the Golgi complex 
passes through the ER-Golgi intermediate compartment (ERGIC). ERGIC is a site of 
anterograde and retrograde sorting under the control of COPI coat proteins, Rab and Arf 
GTPases21. Vesicles exiting from this compartment are either directed to the Golgi or back to 
the ER, depending on the cargo, the ARF-GTPase isoform involved in coat recruitment, and 
on Rab effectors. ERGIC mainly harbors two Rabs that have opposing functions. Rab2 likely 
promotes the formation of vesicles returning to the ER22, whereas Rab1 isoforms are 
involved in ER to ERGIC and ERGIC to cis-Golgi transport23. Indirect evidence for GPCR 
trafficking through the ERGIC has been provided by studies analyzing the effects of Rab1 
and Rab2 proteins on receptor export. Forward trafficking of both the angiotensin AT1 
receptor and the ß2-adrenoceptor were impaired by siRNA-mediated knockout of Rab1b and 
overexpression of dominant-negative Rab1a24. Surprising, trafficking of the α2B-adrenoceptor 
was not affected, suggesting receptor-specific pathways. The surface expression of both ß2- 
and α2B- adrenoceptors was perturbed by Rab2 mutants or siRNA-promoted inhibition of 
Rab2 25. 
The Golgi complex is composed of stacks of flattened cisternae. Each layer of the 
stack, from cis-Golgi to the trans-Golgi network (TGN) contains glycosyltransferases. ER to 
Golgi carriers join the Golgi stack by fusing with cis cisternae26. The transport mechanisms of 
cargo and enzymes through the Golgi stack has not been completely elucidated and lead to 
conflicting models27. Once in the Golgi, cargo proteins may be sorted to the plasma 
membrane, the endosomal system or the ER. Retrograde transport to the ER is likely 
involved in re-targeting misfolded proteins to the ERAD28.  Other defective proteins are 
targeted to lysosomal degradation after sorting to endosomes28. Studies of δ-opioid (DOP) 
receptor glycosylation demonstrated that its O-glycosylation (on Ser or Thre residues) and 
final processing of N-linked oligosaccharides occur in different compartments of the Golgi29. 
Perturbing the function of the Rab6 GTPAse, which regulates vesicular transport in the 
Golgi30, inhibited the anterograde transport of Drosophila rhodopsin31 and of mammalian 
GPCRs 25. There is no evidence for GPCR sorting from the Golgi to endosomes or ER and it 
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remains unknown whether GPCR targeting to the cell surface from the Golgi is regulated. 
However, a recent report indicates that the N-terminus of the α2B-adrenoceptor may contain a 
signal to exit from the Golgi.  Indeed, a receptor mutant, in which adjacent Tyr and Ser amino 
acid residues were substituted, was totally trapped in this organelle32.  
 
GPCR oligomerization might control receptor maturation and cell surface translocation 
Most GPCRs may exist as either homodimers or heterodimers. Dimerization seems to 
occur in the ER where it could have an important role in biosynthesis and quality control of 
newly synthesized receptors33. Heterodimerization can mask retention signals present in the 
sequence of some receptors, such as the GABAB(1)34, which are constitutively trapped in the 
ER in the absence of maturation partners. In contrast, the mechanism by which GPCR 
homodimerization might affect ER exit remains to be elucidated. A plausible hypothesis is 
that homodimerization might help receptor folding. Association of nascent polypeptides with 
chaperones prevents unproductive interactions with the environment that result in protein 
aggregation35. Hydrophobic regions (such as membrane spanning domains of GPCRs) are 
particularly prone to non-specific aggregation. Thus, the ordered association of two nascent 
GPCR polypeptides via their transmembrane regions (often constituting the dimerization 
interface) could hide a significant proportion of the exposed hydrophobic surface and 
facilitate correct folding. The hypothesis that in a GPCR dimer receptor protomers may serve 
as folding chaperones one to each other, is consistent with the fact that functional GPCR 
heterodimers have been obtained in reconstituted cell models containing receptors, which do 
not “meet” in real life. In these artificial conditions, where two distinct GPCR polypeptides are 
forced to enter simultaneously in the ER, if they display sufficient structure-driven propensity 
to assemble, they may form heterodimers. Homodimerization might also contribute to quality 
control. Dimeric receptors are likely to be structurally symmetric. Random mutations affecting 
the overall structure of one protomer, may generate asymmetry within the dimer. Checking 
for symmetry could represent a simple method for ER quality-control mechanisms to 
recognize and retain nascent mutations, for disposal via the ERAD. Consistent with this 
model, mutant ER-retained GPCRs generally display dominant negative effect of over wild 
type forms in heterozygous individuals or in reconstituted cellular models33.  
   
Changing Paradigms  
 
GPCRs displaying regulated translocation to the plasma membrane from intracellular stores.  
It is commonly believed that, in the absence of agonist-promoted endocytosis, 
GPCRs are mainly expressed at the cell surface, but this may not always be the case. The 
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protease-activated receptor (PAR) family represents a well-known example. Thrombin 
receptors (PAR1 and PAR2) are irreversibly activated by cleavage, internalized and 
degraded in lysosomes. A large pool of intracellular receptor, mostly localized in the Golgi 
apparatus and protected from activation by thrombin, is translocated to the plasma 
membrane upon activation of cell surface receptors. Replenishment of plasma membrane 
thrombin receptors is correlated with recovery of thrombin responsiveness36.  
Similarly, regulated pools of intracellular dopamine D1 receptors exist in tubular renal 
cells. In these cells, receptor recruitment from cytosolic stores to the plasma membrane is 
elicited by agonist activation of cell surface receptors37 or via atrial natriuretic peptide-
dependent heterologous activation38.  An analogous phenomenon was also reported for α1A-
adrenoceptors in response to neuropeptide Y stimulation38, leading to the concept that 
receptor recruitment to the plasma membrane might be a mechanism for receptor 
sensitization. Selective up-regulation of D1 receptor was subsequently reported in neuronal 
dendritic spines upon NMDA receptor activation and increased intracellular calcium39. The 
recruitment of renal D1 receptor seems to occur via Golgi-derived vesicles and requires an 
intact microtubular network40.  
Another model of regulated cell surface GPCR delivery, is represented by DOP 
receptor in neuronal cells41. Only a small fraction of DOP receptors is localized at the 
neuronal plasma membrane42, consistent with their low physiological involvement in acute 
pain response43. Sustained stimulation of µ-opioid receptors can redistribute DOP receptors 
to neuronal plasma membranes in vivo and improve DOP-dependent antinociceptive 
effects44,45. It was suggested that cell surface translocation of DOP receptor from intracellular 
compartments might account for the enhanced effect of DOP-targeting drugs during chronic 
pain41. Several stimuli may elicit DOP receptor translocation, including the rise in intracellular 
calcium by either release from intracellular stores or direct opening of ion channels39.  
Several other GPCRs inefficiently expressed at the plasma membrane, such as the 
odorant receptors46, the human GnRH receptor47, the α1D-adrenoceptor48 and the LSH 
receptor49, might represent other candidates for regulated translocation to the cell surface.  
 
The increasing number of non-conventional chaperones and escorts assisting GPCR 
translocation to the plasma membrane (Table 1).  
 
 Some proteins may necessitate the specialized assistance of specific chaperones in 
the ER to fold properly. These so-called “private” chaperones assist nascent proteins in 
various ways. Outfitters50, are chaperones or enzymes that directly participate in the folding 
of their cognate proteins. A few private chaperones involved in GPGR folding have been 
reported. NinaA and RANBP2, two cyclophilin type II proteins displaying peptidyl-prolyl cis-
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trans isomerase activity, function as chaperones for Drosophila and vertebrate rhodopsin, 
respectively51, 52. Rhodopsin also interacts with HSJ1b, a protein member of the DnaJ/Hsp40 
chaperone family53. In neurons, HSJ1 proteins, which function at the cytosolic face of the ER, 
facilitate the transfer of “client” proteins onto Hsc70 chaperones and their subsequent 
ubiquitylation and sorting to the proteasome54. Thus, HSJ1 isoforms likely participate in 
ERAD and protect neurons against cytotoxic protein aggregation. Another group of GPCR 
private chaperones falls in the category of escort proteins50, which bind nascent proteins in 
the ER and escort them to the Golgi complex and the plasma membrane.  
During the past ten years, a vast array of membrane-associated or cytoplasmic 
proteins has been identified, which constitutively interact with GPCRs within intracellular 
compartments and facilitate their cell surface expression. These proteins functionally behave 
like GPCR chaperones or escorts although they often display other biological roles. They 
were often identified by expression-cloning approaches or two-hybrid screens aimed to 
identify accessory factors helping the functional expression of “difficult to study” receptors.  
The first example of non-conventional escort proteins for GPCRs is represented by 
receptor-activity-modifying-proteins (RAMPs55). RAMPs are type-I single-transmembrane 
domain proteins with a large N-terminal extracellular domain and a short C-terminus. They 
were initially described as obligatory interacting partners for the cell surface expression of a 
Class-B56 GPCR, the calcitonin-like receptor. RAMPs remain associated with the receptor at 
the cell surface. Interestingly, depending on the associated RAMP, the ligand binding 
properties of the calcitonin-like receptor vary, RAMP1 inducing affinity for the calcitonin gene-
related peptide (CGRP) whereas RAMP2 determines an adrenomedullin receptor 
phenotype57. Subsequent studies uncovered that RAMPs also aid in the constitutive plasma 
membrane translocation of a Class-C GPCR, the calcium-sensing receptor (CaS)58. 
However, some observations suggest that being an escort protein for GPCRs is not the 
principal physiological function of RAMPs. First, RAMPs are almost ubiquitous, contrasting 
with the restricted tissue distribution of calcitonin-like57 and CaS receptor58. Second, the cell 
surface expression of other RAMP-interacting Class-B GPCRs (VPAC, parathyroid hormone, 
glucagon and glucagon-like peptide receptors), is not affected by their association with 
RAMPs55. 
 For a long time, the study of odorant receptors has been hampered by the lack of 
functional cell surface expression in heterologous cells, raising the hypothesis that odorant 
tissue must contain specific auxiliary factors regulating their plasma membrane trafficking. 
Single transmembrane proteins named RTP1, RTP2 (Receptor Transporting Protein 1 and 2) 
and REEP1 (Receptor Expression Enhancing Protein 1) were finally found to permit 
functional cell surface targeting of odorant receptors in fibroblasts46, reminiscent of previous 
studies in C. elegans, in which odorant receptor localization to olfactory cilia required 
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interaction with the ODR-4 transmembrane protein59. Members of the RTP and REEP 
families display a much more diffuse distribution than the olfactory epithelium, suggesting 
that these proteins may regulate other GPCRs and/or exhibit additional functions. In 
particular, RTP and REEP mRNAs were detected in human circumvallate papillae and testis, 
which are the sites of bitter taste (TAS2) receptor expression. Experiments in heterologous 
cells confirmed the enhancement of TAS2 receptor cell surface targeting upon interaction 
with RTP3-4 and REEPs60.   
The mammalian vomeronasal organ, a small sensory organ located near the base of 
the nasal septum and involved in the detection of pheromones, contains specific Class-C 
GPCRs, which function as pheromone receptors. These vomeronasal receptors require the 
association with M10s proteins for proper traffic to the plasma membrane61. M10s belong to 
the superfamily of MHC class-I molecules, but are exclusively expressed in the vomeronasal 
organ. As classical MHC molecules, M10s contain an open peptide-binding cleft and 
associate with ß2-microglobulin. It was proposed that M10s, in addition to their escort role, 
might modulate the ligand specificity of vomeronasal receptors (similar to RAMPs) or 
participate in neuronal plasticity62.  
As for odorant receptors, it has been very difficult to obtain functional expression of 
exogenous adrenocorticotropin MC2 receptor, except in cells of adrenocortical origin, 
suggesting that MC2 receptor expression may require an adrenal-specific accessory factor. In 
a genetic disease, the familial glucocorticoid deficiency (FGD), the adrenal cortex is resistant 
to adrenocorticotropin. By investigating patients with FGD and normal MC2 receptor, 
mutations were identified in a gene encoding a 19-kDa single-transmembrane domain 
protein, named MC2 receptor accessory protein (MRAP). MRAP was found to interact with 
MC2R and to regulate its trafficking from the endoplasmic reticulum to the cell surface63, 64. 
This example illustrates particularly well the physiopathological relevance of the interaction 
between a GPCR and a “private” escort protein. 
Another similar example comes from studies in mice. Abnormal serotonin signaling 
has been implicated in the pathophysiology of depression. Cell surface density and function 
of the serotonin 5-HT1B receptors are decreased in knockout mice for p1165 (also known as 
calpactin I- or annexin II-light chain) a member of the S100 EF-hand calcium-dependent 
signaling modulators66. These mice exhibit a depression-like phenotype. The distribution of 
p11 mRNA in the brain resembles that of 5-HT1B receptor mRNA, p11 specifically interacts 
with 5-HT1B receptors (not with other serotonin or dopamine receptors), and colocalizes with 
the receptor at the cell surface of transfected cells65. Interestingly, p11 is increased in the 
brain of mice treated with antidepressants and reduced in depressed patients. 
As for p11, other GPCR-interacting proteins may control plasma membrane receptor 
targeting without traveling to the cell surface. A well-known example is the ER-membrane-
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associated protein, DRiP78. Overexpression or down-modulation of this putative two-
transmembrane domain protein leads to ER retention of D1 receptors, reduced ligand 
binding, and impaired kinetics of receptor glycosylation67. DRiP78 binds to a FXXXFXXXF 
motif found in the C-terminus of various GPCRs, supporting the hypothesis that DRiP78 may 
function as a chaperone for several receptors. Accordingly, a subsequent study indicated a 
role of DRiP78 in the maturation of the AT1 angiotensin II receptor68. Noteworthy, DRiP78 
also specifically interacts with Gγ subunits of heterotrimeric G proteins, protecting them from 
degradation until a stable partner (cognate Gβ subunit) is provided. These results suggest a 
chaperone role of DRiP78 in the assembly of Gβγ subunits69. 
A membrane-associated Golgi protein, ATBP50 (for AT2 receptor binding protein of 
50 kDa) was reported to bind to the cytoplasmic carboxyterminal tail of the angiotensin AT2 
receptor and to control its cell surface expression, as demonstrated by receptor retention 
within intracellular compartments after inhibition of ATBP50 expression70. ATBP50 and two 
splice variants of the same gene share two myosin-like coiled-coil regions and form homo 
and hetero-dimers in vitro. These proteins display a much broader distribution than the AT2 
receptor, consistent with additional functions or with a more general role of escort protein for 
other GPCRs. 
Another example of intracellular protein, interacting with the carboxyterminal tail of a 
GPCR (and also the first intracellular loop) and regulating its cell surface expression, is 
represented by RACK1 (from Receptor for Activated C-Kinase 1)71. RACK1 is an ER protein 
that constitutively binds the thromboxane A2 receptor (TPß). The cell surface expression of 
TPß was directly correlated with the concentration of RACK1: in cells with low RACK1 after 
specific siRNA treatment, TPß was retained in the ER. Interestingly, RACK1 displays 
selectivity for GPCRs since its expression level was able to affect the cell surface distribution 
of the chemokine receptor CXCR4 but not that of the ß2-adrenoceptor or prostanoid DP 
receptors. 
Comparable specificity was documented for GEC1, a 117-residue protein, member of 
the microtubule associated protein (MAP) family72.  GEC1 interacts in the Golgi and the ER 
with the C-terminus of κ-opioid (KOP) receptors, but not with that of µ or δ subtypes. GEC1 
expression enhanced the level of mature fully glycosylated forms of KOP receptors, and 
facilitated trafficking of KOP receptor to the cell surface. GEC1 levels appear to be tightly 
regulated, as indicated by a toxic effect of overexpression. Moreover, because of its broad 
tissue distribution, GEC1 might participate in cell trafficking of other membrane proteins72. 
Finally a number of GPCR-interacting proteins, such as the dynein light-chain subunit 
TcTex, Homer proteins and Filamin A, were reported to connect rhodopsin73, glutamate 
receptors74 and dopamine75 receptors, respectively, to the cytoskeleton, participating by this 
mean to their final subcellular localization. At least in the case of the visual receptor, this 
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targeting function is also associated with an escort/chaperone-like role, as indicated by toxic 
effects of rhodopsin mutations, which inhibit the interaction with TcTex73. 
 
Proteins that negatively regulate GPCR export via retention. 
A simple explanation of GPCR retention within intracellular compartments in the 
absence of appropriate signals of forward export or in the case of a lack of “private” 
chaperones or escort proteins, might be the persistent interaction with proteins of the general 
quality-control machinery. Although this hypothesis remains plausible, some observations 
argue for the existence of specific retention mechanisms.  
For example, the second extracellular loop of PAR2 was shown to interact with the N-
terminal domain of the Golgi-resident type I transmembrane protein p24A. PAR2 is trapped 
in the Golgi because of this interaction. Upon activation of cell surface PAR2, the small G 
protein ARF1 is recruited in its GDP-bound form, to Golgi membranes, where a specific 
exchange factor activates ARF1. This process results in the dissociation of PAR2 from p24A 
and receptor sorting to the plasma membrane76. During development, a GPCR-retaining 
protein was reported to control the surface receptor availability of Frizzled (FZD), a GPCR, 
which promotes caudalizing signals. This ER-resident protein, Shisa, is specifically 
expressed in head ectoderm, where it binds to and inhibits cell surface trafficking of FZD. 
Shisa-mediated receptor retention thus constitutes a mechanism to control head-tail 
polarity77. Although evidence for receptor-specific retention mechanisms is still limited for 
GPCRs, other recent examples exist for growth-factor receptors78, suggesting that this field 
may rapidly evolve in the near future.  
 
Concluding remarks and perspectives. 
The emerging picture of GPCR trafficking from biosynthetic compartments to the 
plasma membrane appears much more sophisticated than expected, particularly if the recent 
hypothesis of large signaling complexes containing GPCRs, G proteins and effectors being 
assembled during maturation79, is confirmed by future studies. 
Several receptors are retained within intracellular compartments waiting for external 
signals that control their release from molecular tethers. In most cases, the pathways 
connecting signaling events with receptor export and the entity of the tethers have not been 
identified yet. Moreover, the subcellular location of retained receptors is not unique, 
implicating at least the ER and the Golgi complex.  
Many GPCRs are constitutively associated with a long list of “private” chaperones or 
escort proteins, which are necessary for their proper targeting to the plasma membrane. How 
general this phenomenon may be, what the mechanisms involved in receptor retention and 
release are and the potential connection between this phenomenon and signal-regulated 
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transport remain to be elucidated.  Moreover, these private chaperones, which often display 
other cellular functions, might actually assist multiple GPCRs and possibly other integral 
membrane proteins in their trafficking to the cell surface.  
Several conserved motifs have been identified in the sequence of many GPCRs, 
which may have some role in their forward trafficking. These motifs represent a molecular 
code determining the association with proteins that retain or assist GPCR in their journey 
through biosynthetic compartments. Deciphering the code is still a task that lies ahead. 
Finally, the issue of GPCR maturation and trafficking to the cell surface is already an 
important issue in human health, as several receptor mutants leading to intracellular 
retention have been identified, which cause disease via impaired signaling80. Maturation and 
trafficking of these mutated receptors can be improved by membrane-permeant small 
molecules, which bind to retained receptors and induce export-competent conformational 
changes81. Thus, improving our knowledge on the routing regulation of this important class of 
membrane receptors will probably elicit the development of new therapeutical approaches to 




Thank you to Michel Bouvier and Ralf Jockers for the critical reading of the 






1. Higy, M., et al. (2004) Topogenesis of membrane proteins at the endoplasmic 
reticulum. Biochemistry 43, 12716-12722 
2. Krebs, M.P., et al. (2004) Quality control of integral membrane proteins. Trends 
Biochem Sci 29, 648-655 
3. Ellgaard, L., and Helenius, A. (2003) Quality control in the endoplasmic reticulum. Nat 
Rev Mol Cell Biol 4, 181-191 
4. Hebert, D.N., and Molinari, M. (2007) In and out of the ER: protein folding, quality 
control, degradation, and related human diseases. Physiol Rev 87, 1377-1408 
5. Tsai, B., et al. (2002) Retro-translocation of proteins from the endoplasmic reticulum 
into the cytosol. Nat Rev Mol Cell Biol 3, 246-255 
6. Siffroi-Fernandez, S., et al. (2002) Association of the thyrotropin receptor with calnexin, 
calreticulin and BiP. Efects on the maturation of the receptor. Eur J Biochem 269, 
4930-4937 
7. Mizrachi, D., and Segaloff, D.L. (2004) Intracellularly located misfolded glycoprotein 
hormone receptors associate with different chaperone proteins than their cognate wild-
type receptors. Mol Endocrinol 18, 1768-1777 
8. Rozell, T.G., et al. (1998) Association of gonadotropin receptor precursors with the 
protein folding chaperone calnexin. Endocrinology 139, 1588-1593 
9. Morello, J.P., et al. (2001) Association of calnexin with wild type and mutant AVPR2 
that causes nephrogenic diabetes insipidus. Biochemistry 40, 6766-6775 
10. Lanctot, P.M., et al. (2006) Role of N-glycan-dependent quality control in the cell-
surface expression of the AT1 receptor. Biochem Biophys Res Commun 340, 395-402 
11. Rosenbaum, E.E., et al. (2006) Calnexin is essential for rhodopsin maturation, Ca2+ 
regulation, and photoreceptor cell survival. Neuron 49, 229-241 
12. Lu, M., et al. (2003) Endoplasmic reticulum retention, degradation, and aggregation of 
olfactory G-protein coupled receptors. Traffic 4, 416-433 
13. Fan, J., et al. (2005) A point mutation in the human melanin concentrating hormone 
receptor 1 reveals an important domain for cellular trafficking. Mol Endocrinol 19, 2579-
2590 
14. Petaja-Repo, U.E., et al. (2001) Newly synthesized human delta opioid receptors 
retained in the endoplasmic reticulum are retrotranslocated to the cytosol, 
deglycosylated, ubiquitinated, and degraded by the proteasome. J Biol Chem 276, 
4416-4423 
15. Robben, J.H., et al. (2005) Characterization of vasopressin V2 receptor mutants in 
nephrogenic diabetes insipidus in a polarized cell model. Am J Physiol Renal Physiol 
289, F265-272 
16. Daulat, A.M., et al. (2007) Purification and identification of G protein-coupled receptor 
protein complexes under native conditions. Mol Cell Proteomics 6, 835-844 
17. Barlowe, C. (2003) Signals for COPII-dependent export from the ER: what's the ticket 
out? Trends Cell Biol 13, 295-300 
18. Dong, C., et al. (2008) Endoplasmic reticulum export of adrenergic and angiotensin II 
receptors is differentially regulated by Sar1 GTPase. Cell Signal 20, 1035-1043 
19. Aridor, M., et al. (1998) Cargo selection by the COPII budding machinery during export 
from the ER. J Cell Biol 141, 61-70 
20. Dong, C., et al. (2007) Regulation of G protein-coupled receptor export trafficking. 
Biochim Biophys Acta 1768, 853-870 
21. Appenzeller-Herzog, C., and Hauri, H.P. (2006) The ER-Golgi intermediate 
compartment (ERGIC): in search of its identity and function. J Cell Sci 119, 2173-2183 
22. Tisdale, E.J. (2003) Rab2 interacts directly with atypical protein kinase C (aPKC) 
iota/lambda and inhibits aPKCiota/lambda-dependent glyceraldehyde-3-phosphate 
dehydrogenase phosphorylation. J Biol Chem 278, 52524-52530 
 12 
23. Moyer, B.D., et al. (2001) Rab1 interaction with a GM130 effector complex regulates 
COPII vesicle cis--Golgi tethering. Traffic 2, 268-276 
24. Wu, G., et al. (2003) Distinct pathways for the trafficking of angiotensin II and 
adrenergic receptors from the endoplasmic reticulum to the cell surface: Rab1-
independent transport of a G protein-coupled receptor. J Biol Chem 278, 47062-47069 
25. Dong, C., and Wu, G. (2007) Regulation of anterograde transport of adrenergic and 
angiotensin II receptors by Rab2 and Rab6 GTPases. Cell Signal 19, 2388-2399 
26. Trucco, A., et al. (2004) Secretory traffic triggers the formation of tubular continuities 
across Golgi sub-compartments. Nat Cell Biol 6, 1071-1081 
27. Pfeffer, S.R. (2007) Unsolved mysteries in membrane traffic. Annu Rev Biochem 76, 
629-645 
28. Arvan, P., et al. (2002) Secretory pathway quality control operating in Golgi, 
plasmalemmal, and endosomal systems. Traffic 3, 771-780 
29. Petaja-Repo, U.E., et al. (2000) Export from the endoplasmic reticulum represents the 
limiting step in the maturation and cell surface expression of the human delta opioid 
receptor. J Biol Chem 275, 13727-13736 
30. Jordens, I., et al. (2005) Rab proteins, connecting transport and vesicle fusion. Traffic 
6, 1070-1077 
31. Shetty, K.M., et al. (1998) Rab6 regulation of rhodopsin transport in Drosophila. J Biol 
Chem 273, 20425-20430 
32. Dong, C., and Wu, G. (2006) Regulation of anterograde transport of alpha2-adrenergic 
receptors by the N termini at multiple intracellular compartments. J Biol Chem 281, 
38543-38554 
33. Bulenger, S., et al. (2005) Emerging role of homo- and heterodimerization in G-protein-
coupled receptor biosynthesis and maturation. Trends Pharmacol Sci 26, 131-137 
34. Margeta-Mitrovic, M., et al. (2000) A trafficking checkpoint controls GABA(B) receptor 
heterodimerization. Neuron 27, 97-106. 
35. Gething, M.J., and Sambrook, J. (1992) Protein folding in the cell. Nature 355, 33-45 
36. Hein, L., et al. (1994) Intracellular targeting and trafficking of thrombin receptors. A 
novel mechanism for resensitization of a G protein-coupled receptor. J Biol Chem 269, 
27719-27726 
37. Brismar, H., et al. (1998) Dopamine-induced recruitment of dopamine D1 receptors to 
the plasma membrane. Proc Natl Acad Sci U S A 95, 5573-5578 
38. Holtback, U., et al. (1999) Receptor recruitment: a mechanism for interactions between 
G protein-coupled receptors. Proc Natl Acad Sci U S A 96, 7271-7275 
39. Scott, L., et al. (2002) Selective up-regulation of dopamine D1 receptors in dendritic 
spines by NMDA receptor activation. Proc Natl Acad Sci U S A 99, 1661-1664 
40. Kruse, M.S., et al. (2003) Recruitment of renal dopamine 1 receptors requires an intact 
microtubulin network. Pflugers Arch 445, 534-539 
41. Cahill, C.M., et al. (2007) Trafficking of delta-opioid receptors and other G-protein-
coupled receptors: implications for pain and analgesia. Trends Pharmacol Sci 28, 23-
31 
42. Cahill, C.M., et al. (2001) Immunohistochemical distribution of delta opioid receptors in 
the rat central nervous system: evidence for somatodendritic labeling and antigen-
specific cellular compartmentalization. J Comp Neurol 440, 65-84 
43. Kieffer, B.L. (1999) Opioids: first lessons from knockout mice. Trends Pharmacol Sci 
20, 19-26 
44. Cahill, C.M., et al. (2001) Prolonged morphine treatment targets delta opioid receptors 
to neuronal plasma membranes and enhances delta-mediated antinociception. J 
Neurosci 21, 7598-7607 
45. Morinville, A., et al. (2003) Regulation of delta-opioid receptor trafficking via mu-opioid 
receptor stimulation: evidence from mu-opioid receptor knock-out mice. J Neurosci 23, 
4888-4898 
46. Saito, H., et al. (2004) RTP family members induce functional expression of 
mammalian odorant receptors. Cell 119, 679-691 
 13 
47. Janovick, J.A., et al. (2006) Regulation of G protein-coupled receptor trafficking by 
inefficient plasma membrane expression: molecular basis of an evolved strategy. J Biol 
Chem 281, 8417-8425 
48. Uberti, M.A., et al. (2005) Heterodimerization with beta2-adrenergic receptors promotes 
surface expression and functional activity of alpha1D-adrenergic receptors. J 
Pharmacol Exp Ther 313, 16-23 
49. Pietila, E.M., et al. (2005) Inefficient maturation of the rat luteinizing hormone receptor. 
A putative way to regulate receptor numbers at the cell surface. J Biol Chem 280, 
26622-26629 
50. Herrmann, J.M., et al. (1999) Out of the ER--outfitters, escorts and guides. Trends Cell 
Biol 9, 5-7 
51. Baker, E.K., et al. (1994) The cyclophilin homolog NinaA functions as a chaperone, 
forming a stable complex in vivo with its protein target rhodopsin. Embo J 13, 4886-
4895 
52. Ferreira, P.A., et al. (1996) Cyclophilin-related protein RanBP2 acts as chaperone for 
red/green opsin. Nature 383, 637-640 
53. Chapple, J.P., and Cheetham, M.E. (2003) The chaperone environment at the 
cytoplasmic face of the endoplasmic reticulum can modulate rhodopsin processing and 
inclusion formation. J Biol Chem 278, 19087-19094 
54. Westhoff, B., et al. (2005) HSJ1 is a neuronal shuttling factor for the sorting of 
chaperone clients to the proteasome. Curr Biol 15, 1058-1064 
55. Parameswaran, N., and Spielman, W.S. (2006) RAMPs: the past, present and future. 
Trends Biochem Sci 31, 631-638 
56. Horn, F., et al. (1998) GPCRDB: an information system for G protein-coupled 
receptors.   
Nucleic Acids Res 26, 275-279 
57. McLatchie, L.M., et al. (1998) RAMPs regulate the transport and ligand specificity of 
the calcitonin- receptor-like receptor. Nature 393, 333-339 
58. Bouschet, T., et al. (2005) Receptor-activity-modifying proteins are required for forward 
trafficking of the calcium-sensing receptor to the plasma membrane. J Cell Sci 118, 
4709-4720 
59. Dwyer, N.D., et al. (1998) Odorant receptor localization to olfactory cilia is mediated by 
ODR-4, a novel membrane-associated protein. Cell 93, 455-466 
60. Behrens, M., et al. (2006) Members of RTP and REEP gene families influence 
functional bitter taste receptor expression. J Biol Chem 281, 20650-20659 
61. Loconto, J., et al. (2003) Functional expression of murine V2R pheromone receptors 
involves selective association with the M10 and M1 families of MHC class Ib 
molecules. Cell 112, 607-618 
62. Olson, R., et al. (2006) MHC homologs in the nervous system — they haven’t lost their 
groove. Current Opinion in Neurobiology 16, 351-357 
63. Metherell, L.A., et al. (2005) Mutations in MRAP, encoding a new interacting partner of 
the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat Genet 37, 166-
170 
64. Cooray, S.N., et al. (2008) The melanocortin 2 receptor accessory protein exists as a 
homodimer and is essential for the function of the melanocortin 2 receptor in the 
mouse y1 cell line. Endocrinology 149, 1935-1941 
65. Svenningsson, P., et al. (2006) Alterations in 5-HT1B receptor function by p11 in 
depression-like states. Science 311, 77-80 
66. Donato, R. (1999) Functional roles of S100 proteins, calcium-binding proteins of the 
EF-hand type. Biochim Biophys Acta 1450, 191-231 
67. Bermak, J.C., et al. (2001) Regulation of transport of the dopamine D1 receptor by a 
new membrane- associated ER protein. Nat Cell Biol 3, 492-498. 
68. Leclerc, P.C., et al. (2002) A polyaromatic caveolin-binding-like motif in the cytoplasmic 
tail of the type 1 receptor for angiotensin II plays an important role in receptor 
trafficking and signaling. Endocrinology 143, 4702-4710 
 14 
69. Dupre, D.J., et al. (2007) Dopamine receptor-interacting protein 78 acts as a molecular 
chaperone for G-gamma subunits before assembly with G-beta. J Biol Chem 282, 
13703-13715 
70. Wruck, C.J., et al. (2005) Regulation of transport of the angiotensin AT2 receptor by a 
novel membrane-associated Golgi protein. Arterioscler Thromb Vasc Biol 25, 57-64 
71. Parent, A., et al. (2008) RACK1 regulates the cell surface expression of the G protein-
coupled receptor for thromboxane A(2). Traffic 9, 394-407 
72. Chen, C., et al. (2006) GEC1 interacts with the kappa opioid receptor and enhances 
expression of the receptor. J Biol Chem 281, 7983-7993 
73. Tai, A.W., et al. (1999) Rhodopsin's carboxy-terminal cytoplasmic tail acts as a 
membrane receptor for cytoplasmic dynein by binding to the dynein light chain Tctex-1. 
Cell 97, 877-887 
74. Ango, F., et al. (2000) Dendritic and axonal targeting of type 5 metabotropic glutamate 
receptor is regulated by homer1 proteins and neuronal excitation. J Neurosci 20, 8710-
8716 
75. Lin, R., et al. (2001) Dopamine D2 and D3 receptors are linked to the actin 
cytoskeleton via interaction with filamin A. Proc Natl Acad Sci U S A 98, 5258-5263. 
76. Luo, W., et al. (2007) p24A, a type I transmembrane protein, controls ARF1-dependent 
resensitization of protease-activated receptor-2 by influence on receptor trafficking. J 
Biol Chem 282, 30246-30255 
77. Yamamoto, A., et al. (2005) Shisa promotes head formation through the inhibition of 
receptor protein maturation for the caudalizing factors, Wnt and FGF. Cell 120, 223-
235 
78. Couturier, C., et al. (2007) Silencing of OB-RGRP in mouse hypothalamic arcuate 
nucleus increases leptin receptor signaling and prevents diet-induced obesity. Proc 
Natl Acad Sci U S A 104, 19476-19481 
79. Dupre, D.J., et al. (2006) Seven transmembrane receptor core signaling complexes are 
assembled prior to plasma membrane trafficking. J Biol Chem 281, 34561-34573 
80. Conn, P.M., et al. (2007) G protein-coupled receptor trafficking in health and disease: 
lessons learned to prepare for therapeutic mutant rescue in vivo. Pharmacol Rev 59, 
225-250 
81. Bernier, V., et al. (2004) Pharmacological chaperone action on G-protein-coupled 












Figure 1. Subcellular events involved in GPCR maturation and cell surface export.
The scheme represents a step-by-step outline of GPCR synthesis and transport along the
secretory pathway. Numbered boxes refer to either general mechanisms of protein
transport (in black) or to GPCR-specific events (in blue). The proteins indicated in the
boxes are described in the text and have all been shown to specifically contribute to GPCR
transport.
ER: endoplasmic reticulum; ERGIC: ER-Golgi intermediate compartment; ERAD:ER-
associated degradation pathway; COPII: coat protein II (or coatomer), involved in the
transport of proteins from the rough endoplasmic reticulum to the Golgi apparatus. COPI:
coat protein I, found on Golgi membrane at steady state, and involved in the formation of
vesicles leaving the Golgi, including those of the retrograde transport to the ER.
Cotranslational entry in the ER via
the retrotranslocon, and folding






Private GPCR chaperones and
escort proteins (see Table 1)
ER exit sites and COPII-coated
buds and vesicles, the formation of
which is regulated by the Sar1
GTPase
Proteins involved in anterograde or
retrograde sorting in the ERGIC,








Retrograde transport from the
Golgi to the ER via COPI vesicles 6




Sites of GPCR retention within
the biosynthetic pathway:
Golgi (p24A,PAR2)
ER (Shisa, Frizzled) 8
GPCR
Table 1. Non-classical chaperones and escorts, which assist GPCR translocation to  




Abbreviations: AMY, amylin; CaS, calcium-sensing;CGRP, calcitotonin gene-related peptide; 
TM, transmembrane 
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